{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:47:19Z","timestamp":1790459239840,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.nano.2017.12.009","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T18:22:42Z","timestamp":1514398962000},"page":"875-882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Extracellular vesicles or free circulating DNA: where to search for BRAF and cKIT mutations?"],"prefix":"10.1016","volume":"14","author":[{"given":"Jennifer","family":"Klump","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Phillipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Follo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Eremin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrun","family":"Nestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"von Bubnoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Nazarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2017.12.009_bb0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ccell.2017.01.002","article-title":"Liquid Biopsies, What We Do Not Know (Yet)","volume":"31","author":"Bardelli","year":"2017","journal-title":"Cancer cell"},{"key":"10.1016\/j.nano.2017.12.009_bb0010","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","article-title":"Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy","volume":"6","author":"Alix-Panabieres","year":"2016","journal-title":"Cancer discovery"},{"key":"10.1016\/j.nano.2017.12.009_bb0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.molonc.2016.01.009","article-title":"Liquid biopsy: Potential and challenges","volume":"10","author":"Pantel","year":"2016","journal-title":"Molecular oncology"},{"key":"10.1016\/j.nano.2017.12.009_bb0020","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2003.02.006","article-title":"Quantification of free circulating DNA as a diagnostic marker in lung cancer","volume":"21","author":"Sozzi","year":"2003","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.nano.2017.12.009_bb0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13058-015-0645-5","article-title":"Circulating DNA as biomarker in breast cancer","volume":"17","author":"Schwarzenbach","year":"2015","journal-title":"Breast cancer research: BCR"},{"key":"10.1016\/j.nano.2017.12.009_bb0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2008.03.021","article-title":"Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer","volume":"263","author":"Frattini","year":"2008","journal-title":"Cancer letters"},{"key":"10.1016\/j.nano.2017.12.009_bb0035","author":"Maxwell","year":"2017","journal-title":"Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer. Breast cancer research and treatment"},{"key":"10.1016\/j.nano.2017.12.009_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161012","article-title":"Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients","volume":"11","author":"Dietz","year":"2016","journal-title":"PloS one"},{"key":"10.1016\/j.nano.2017.12.009_bb0045","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1158\/1078-0432.CCR-08-3179","article-title":"Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Yen","year":"2009","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.nano.2017.12.009_bb0050","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1158\/1078-0432.CCR-11-0564","article-title":"Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan","volume":"18","author":"Spindler","year":"2012","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.nano.2017.12.009_bb0055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nm.3511","article-title":"Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA","volume":"20","author":"Thierry","year":"2014","journal-title":"Nature medicine"},{"key":"10.1016\/j.nano.2017.12.009_bb0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mrfmmm.2015.05.002","article-title":"Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients","volume":"778","author":"Balgkouranidou","year":"2015","journal-title":"Mutation research"},{"key":"10.1016\/j.nano.2017.12.009_bb0065","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-16-3155","article-title":"Early evaluation of circulating tumor DNA as marker of therapeutic efficacy in metastatic colorectal cancer patients (PLACOL study)","author":"Garlan","year":"2017","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.nano.2017.12.009_bb0070","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1074\/jbc.C113.532267","article-title":"Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer","volume":"289","author":"Kahlert","year":"2014","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.nano.2017.12.009_bb0075","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/cr.2014.44","article-title":"Double-stranded DNA in exosomes: a novel biomarker in cancer detection","volume":"24","author":"Thakur","year":"2014","journal-title":"Cell research"},{"key":"10.1016\/j.nano.2017.12.009_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annual review of cell and developmental biology"},{"key":"10.1016\/j.nano.2017.12.009_bb0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"The Journal of cell biology"},{"key":"10.1016\/j.nano.2017.12.009_bb0090","doi-asserted-by":"crossref","first-page":"26913","DOI":"10.3402\/jev.v3.26913","article-title":"Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles","volume":"3","author":"Lotvall","year":"2014","journal-title":"Journal of extracellular vesicles"},{"key":"10.1016\/j.nano.2017.12.009_bb0095","doi-asserted-by":"crossref","unstructured":"Witwer, K. W. et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. Journal of extracellular vesicles 2, https:\/\/doi.org\/10.3402\/jev.v2i0.20360 (2013).","DOI":"10.3402\/jev.v2i0.20360"},{"key":"10.1016\/j.nano.2017.12.009_bb0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/ijms17020175","article-title":"Focus on Extracellular Vesicles: New Frontiers of Cell-to-Cell Communication in Cancer","volume":"17","author":"Ciardiello","year":"2016","journal-title":"International journal of molecular sciences"},{"key":"10.1016\/j.nano.2017.12.009_bb0105","author":"Siravegna","year":"2017","journal-title":"Integrating liquid biopsies into the management of cancer. Nature reviews. Clinical oncology"},{"key":"10.1016\/j.nano.2017.12.009_bb0110","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1038\/ncomms15287","article-title":"Exosomes maintain cellular homeostasis by excreting harmful DNA from cells","volume":"8","author":"Takahashi","year":"2017","journal-title":"Nature communications"},{"key":"10.1016\/j.nano.2017.12.009_bb0115","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/annonc\/mdx004","article-title":"High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients","volume":"28","author":"Allenson","year":"2017","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"key":"10.1016\/j.nano.2017.12.009_bb0120","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1158\/1078-0432.CCR-13-0661","article-title":"Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progression","volume":"19","author":"Romano","year":"2013","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.nano.2017.12.009_bb0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood-2004-12-4617","article-title":"Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412","volume":"106","author":"Growney","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.nano.2017.12.009_bb0130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2353\/jmoldx.2006.060070","article-title":"Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology","volume":"8","author":"Benlloch","year":"2006","journal-title":"The Journal of molecular diagnostics: JMD"},{"key":"10.1016\/j.nano.2017.12.009_bb0135","doi-asserted-by":"crossref","first-page":"E968","DOI":"10.1073\/pnas.1521230113","article-title":"Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes","volume":"113","author":"Kowal","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.nano.2017.12.009_bb0140","doi-asserted-by":"crossref","unstructured":"Coumans, F. A. W. et al. Methodological Guidelines to Study Extracellular Vesicles. Circulation research 120, 1632-1648, https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.309417 (2017).","DOI":"10.1161\/CIRCRESAHA.117.309417"},{"key":"10.1016\/j.nano.2017.12.009_bb0145","doi-asserted-by":"crossref","unstructured":"Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current protocols in cell biology Chapter 3, Unit 3 22, https:\/\/doi.org\/10.1002\/0471143030.cb0322s30 (2006).","DOI":"10.1002\/0471143030.cb0322s30"},{"key":"10.1016\/j.nano.2017.12.009_bb0150","first-page":"6997","article-title":"BRAF and RAS mutations in human lung cancer and melanoma","volume":"62","author":"Brose","year":"2002","journal-title":"Cancer research"},{"key":"10.1016\/j.nano.2017.12.009_bb0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000315946","article-title":"Mastocytosis","volume":"95","author":"Brockow","year":"2010","journal-title":"Chemical immunology and allergy"},{"key":"10.1016\/j.nano.2017.12.009_bb0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1101\/sqb.2016.81.030932","article-title":"Discovery of Double-Stranded Genomic DNA in Circulating Exosomes","volume":"81","author":"Kalluri","year":"2016","journal-title":"Cold Spring Harbor symposia on quantitative biology"},{"key":"10.1016\/j.nano.2017.12.009_bb0165","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.4161\/cc.26539","article-title":"Large oncosomes mediate intercellular transfer of functional microRNA","volume":"12","author":"Morello","year":"2013","journal-title":"Cell cycle"},{"key":"10.1016\/j.nano.2017.12.009_bb0170","doi-asserted-by":"crossref","first-page":"30087","DOI":"10.3402\/jev.v4.30087","article-title":"Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper","volume":"4","author":"Lener","year":"2015","journal-title":"Journal of extracellular vesicles"},{"key":"10.1016\/j.nano.2017.12.009_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ijmm.2015.2194","article-title":"Isolation of extracellular vesicles: Determining the correct approach (Review)","volume":"36","author":"Szatanek","year":"2015","journal-title":"International journal of molecular medicine"},{"key":"10.1016\/j.nano.2017.12.009_bb0180","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/blood.V93.11.3956","article-title":"Horizontal transfer of DNA by the uptake of apoptotic bodies","volume":"93","author":"Holmgren","year":"1999","journal-title":"Blood"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963417305877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963417305877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T23:37:06Z","timestamp":1603582626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963417305877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1549963417305877"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2017.12.009","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles or free circulating DNA: where to search for BRAF and cKIT mutations?","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2017.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}